Hear from Tsz Ying Yau of NSW Health from the Serology and Virology Division, Area Virology Laboratory at NSW Health Pathology Randwick, Prince of Wales Hospital in Sydney, at this year’s NRL Workshop on Infectious Disease Testing. The talk entitled, ” Advancing Measles, Mumps and Rubella Testing in Australia for Rapid Diagnosis and Outbreak Prevention”…

This is the final webinar in the three-part educational webinar series on Advances in Gastrointestinal Parasite Testing. In this third webinar, three experts in medical diagnostics, Dr. Susan Madison-Antenucci, Prof. Marc Couturier and Dr. Damien Stark describe the benefits of employing a broader syndromic panel to include the detection of the other leading pathogenic parasites causing GI…

Hear from our Senior Principal Research Scientist, Dr Rohan Baker, in this years’ virtual NRL Workshop on Infectious Diseases. The talk and Q&A discusses the validation of our EasyScreen SARS-CoV-2 Detection Kit on saliva samples, in collaboration with St Vincent’s Health Network Sydney.

This webinar is the first of a three-part series on Advances in Gastrointestinal Protozoa Testing: Molecular Ova and Parasite Investigations that aims to highlight the prevalence of gastrointestinal (GI) protozoan infection, the significant health and economic burden, and the recent advances in rapid and accurate testing techniques. Traditional screening methods for detecting ova and parasites…

This webinar is the second of a three-part series on Advances in Gastrointestinal Protozoa Testing. The first webinar gave a broad overview of the key parasites causing gastrointestinal disease, traditional diagnostic methods used to detect ova and protozoa, and the benefits of employing a molecular approach. In this second live webinar, two leading experts in…

Improvement of Syndromic Screening of Respiratory and Enteric Pathogens with Rapid PCR Cycling Genetic Signatures presents optimised cycling times for six key EasyScreenTM respiratory and gastrointestinal detection kits, enabling faster time-to-result to support laboratory workflow and reporting, and improved patient management.

Genetic Signatures’ CEO Dr John Melki takes part in the Biotech Predictions webinar, discussing the company’s recent financial summary, our ongoing response to the COVID-19 pandemic, and further global impact with products including gastrointestinal infection and sexual health testing.